Zevtera / Mabelio (ceftobiprole)

Indicaton

Acute bacterial skin and skin structure infections (ABSSSI)

Therapeutic indications

Infectious disease

Type of product

Small molecule

Table

Phase

Phase III completed
Partnering status

Not partnered

You may also be interested in

MV-003 Dysbiosis

Dysbiosis ApyraMed promotes microbiome recovery and selection of beneficial bacteria after antibiotic treatment. This results in powerful control of antibiotic-induced enteric infections and metabolic alterations.

MV-001 Clostridioides Difficile

Clostridioides Difficile ApyraVax is suitable for continuous dosing, exploits the already marketed and safe Salmonella Ty21a vaccine strain (Vivotif®) and induces high-affinity secretory IgAs that ensure protection from CDI.

TOTIPHARMACEUTICAL

Polypharmacology for all therapeutic aeras using nano-drug delivery systems